key: cord-0955828-6u4j54ql
authors: Shanbehzadeh, Sanaz; Tavahomi, Mahnaz; Zanjari, Nasibeh; Ebrahimi-Takamjani, Ismail; Amiri-arimi, Somayeh
title: Physical and mental health complications post-COVID-19: Scoping review
date: 2021-05-20
journal: J Psychosom Res
DOI: 10.1016/j.jpsychores.2021.110525
sha: c9e462b8c20773afcb92f42608a9fe544587a55d
doc_id: 955828
cord_uid: 6u4j54ql

Objective Several long-lasting health complications have been reported in previous coronavirus infections. Therefore, the aim of this study was to review studies that evaluated physical and mental health problems post-COVID-19. Methods Articles for inclusion in this scoping review were identified by searching the PubMed, Scopus, Web of Science and Google Scholar databases for items dated from 1 January to 7 November 2020. Observational studies evaluating physical health (musculoskeletal symptoms, functional status) or mental health status with a follow-up period longer than 1 month after discharge or after the onset of symptoms were included. Results This scoping review included 34 studies with follow-up periods of up to 3 months post-COVID-19. The most commonly reported physical health problems were fatigue (range 28% to 87%), pain (myalgia 4.5% to 36%), arthralgia (6.0% to 27%), reduced physical capacity (six-minute walking test range 180 to 561 m), and declines in physical role functioning, usual care and daily activities (reduced in 15% to 54% of patients). Common mental health problems were anxiety (range 6.5% to 63%), depression (4% to 31%) and post-traumatic stress disorder (12.1% to 46.9%). Greater fatigue, pain, anxiety and depression were reported in female patients and individuals admitted to intensive care. An overall lower quality of life was seen up to 3 months post-COVID-19. Conclusions This review highlights the presence of several physical and mental health problems up to 3 months post-COVID-19. The findings point to the need for comprehensive evaluation and rehabilitation post-COVID-19 to promote quality of life.

articles were removed, the titles and abstracts of all remaining articles were screened by two independent reviewers (M.T., S.A.A.) in two steps. Subsequently, the same two reviewers independently screened the full texts of studies to verify that they met the eligibility criteria. In cases of disagreement, a third researcher was consulted (S.S.) to reach a final decision.

Data extraction from included studies:

The data from all included studies were extracted by two independent reviewers (M.T., S.A.A.), and are presented in Tables 1 to 3. The data extracted for each article were author, study design, country, sample size, age, follow-up period, hospitalization period, outcomes and their measurements tools, prevalence of outcomes and mean (standard deviation [SD]) or median (interquartile range [IQR] ) score of each outcome.

Search results: Figure 1 illustrates a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram for the process of searching and selecting eligible studies. We found 7398 studies by searching with syntaxes adapted to each database, and removed 3802 as duplicates. Titles and abstracts were screened for residual studies (n=3596), and 3503 of these were excluded based on irrelevant titles and/or abstracts, which left 93 studies. Full text significant negative effect on HRQOL scores [15] [16] [17] 21] . One study reported that early physical and pulmonary rehabilitation within 72 hours of ICU admission could be effective in improving HRQOL at 1 month and 3 months after hospital discharge [12] . Specific categories of physical and mental health status according to the HRQOL questionnaire are covered in the next two sections, along with the results of other measurements related to physical and mental health.

Physical health status:

Musculoskeletal symptoms:

Fatigue was reported in 28% to 87% of individuals after coronavirus infection. This complication was observed in both hospitalized and nonhospitalized patients, and in those admitted to inpatient wards and the ICU [16, 19, 22, 23] . Seven studies assessed the association between fatigue and COVID-19 severity [16, 21, [24] [25] [26] ; four found greater fatigue in severely ill individuals [16, 21, 26] , and one study reported greater fatigue or physical decline with longer durations of hospital stay [27] . Five studies found normal laboratory tests at follow-up, and suggested there was no association between fatigue and laboratory parameters such as inflammatory markers, cell turnover (leukocyte, neutrophil or lymphocyte counts, neutrophil-tolymphocyte ratio, lactate dehydrogenase, C-reactive protein) or pro-inflammatory molecules (IL-6 or soluble CD25), ferritin or D-dimer [15, 16, 23, 24] . Fatigue was reported in a greater proportion of women [21, 24, 27] and individuals with psychological problems [21, 24] . Across all studies, the prevalence of post-COVID-19 myalgia was 4.5-36%, and the prevalence of post-COVID-19 arthralgia was 6.0-27%. Only one study from China reported no pain at follow-up [25] . Pain was evaluated with health-related questionnaires (EQ-5D, EQ-5D-5L and SF- 36) , and patients reported slight to moderate pain, except in one study that reported moderate to severe pain in 51.6% of individuals admitted to the ICU [28] . Overall, pain was J o u r n a l P r e -p r o o f reported by a greater percentage of recovering individuals post-COVID-19 who experienced severe illness in the acute stage and required hospitalization [16, 19, 26, 29, 30] . A larger proportion of individuals with anxiety and depression reported musculoskeletal symptoms compared to their counterparts without these diagnoses [15, 21, 31] . The studies included in this review reported conflicting results regarding the association between comorbidities and the presence of musculoskeletal symptoms post-COVID-19 [22-24, 26, 30] [32] . Physical activity, mobility, and usual activities were reported to be reduced in 15% to 54% of individuals after their coronavirus infection [12, 15, 17-19, 21, 28, 29, 33] . Five studies reported a decline in physical activity especially for usual care and daily activities in individuals admitted to the ICU J o u r n a l P r e -p r o o f [12, 15, 16, 21, 28] . Three studies reported greater declines in physical role functioning (participation in life despite physical limitations) compared to other components of physical health status [16, 29, 34] .

Mental health status:

The most frequent mental health symptom reported in the studies included in this review was anxiety, with post-COVID-19 prevalences ranging from 6.5% to 63%. The second most frequent psychological symptom was depression, with prevalences ranging between 4% and 31% at follow-up times longer than 1 month post-COVID-19. 31, 33] . Neurocognitive parameter including immediate verbal memory and semantic verbal fluency were moderately impaired in 58.7% and severely impaired in 18.4% of post-COVID-19 patients [33] . More than half of the patients presented at least one stress-related symptom (anxiety, depression, and PTSD) [35] or neurocognitive impairment [33] .

The associations between mental health symptoms and demographic characteristics were evaluated in most studies. Inconsistent findings were reported for the association between age and psychological symptoms: four studies found an inverse relationship [16, 21, 31, 35, 36] , whereas three studies reported no association [4, 31, 33] . Greater psychological impact was J o u r n a l P r e -p r o o f observed in females post-COVID-19, with a 2.2-to 2.5-fold higher odds of developing psychiatric morbidity [36, 21, 29, 33] . Comorbidities (arterial hypertension, coronary artery disease, and diabetes mellitus) were not related to a higher incidence of mental health problems [31, 36, 37] . Previous psychiatric disorders were associated with increased severity of post-COVID-19 mental health symptoms [35, 36] . However, even individuals without previously diagnosed mental health morbidity (74%) reported anxiety and depression symptoms post-COVID-19 [21]. One study reported a significant direct relationship between symptoms of depression and baseline immune responses [38] , and inverse associations were found elsewhere with lung function parameters (forced vital capacity [FVC] ) and post-discharge respiratory symptoms [4, 29] .

This review highlights the presence of several physical and mental health problems post-COVID-19 after follow-up periods of up to 3 months. Among the physical health problems, fatigue was the most common musculoskeletal symptom reported post-COVID-19. Long-lasting fatigue has been reported previously after other viral infections [39] [40] [41] [42] . Several studies have investigated the associations between fatigue and disease severity, gender, age, comorbidity, and a pre-existing diagnosis of depression and/or anxiety [15, 16, 26, 27, 30] . Greater fatigue and pain at follow-up were reported, apparently, by patients who had experienced severe SARS-CoV-2 infection [16, 21, 26] . However, inconsistent findings were reported in studies that evaluated the association between disease severity and fatigue; differences among studies maybe due to the severity criteria used for COVID-19 and to different admission or discharge protocols [16, 21, [24] [25] [26] . Women tended to experience fatigue to a greater extent compared to men [21, J o u r n a l P r e -p r o o f Journal Pre-proof 24, 27] . This is consistent with the higher rate of chronic fatigue syndrome reported in females, which has been linked to stress-related factors [43] .

Physical health declines were found mostly with the physical role functioning, mobility and usual activity [16, 29, 34] , which are related to participation in work and regular daily activities [44] . In addition, reduced physical capacity was evident as lower 6MWT results post-COVID-19 compared to the average value of >650 m in healthy adults [45] , with no decrease in oxygen saturation during testing [12] [13] [14] [15] 46] . These findings suggest a role for factors other than pulmonary dysfunction in reduced physical capacity. Previously, declines in physical activity were reported in individuals who recovered from SARS and experienced restrictions in activities of daily living and work participation [47, 48] . Physical performance should ideally be assessed in a way that includes both functional capacity measurements (e.g., 6MWT, STS), and muscle strength, to gain better insights that can be used in clinical practice. However, only one study evaluated muscle strength at 3-months' post-COVID-19 follow-up, and reported that 18% of individuals admitted to the ICU had acquired weakness [49] . Muscle weakness and acute sarcopenia have been observed in COVID-19 survivors [8, 50] . Among individuals infected with the coronavirus, Paneroni et al. found quadriceps weakness in 86% and biceps brachialis weakness in 73% at hospital discharge [50] . This finding further highlights the importance of evaluating muscle strength at follow-up [51, 52] , because it is associated with poor functional outcomes and long-term disability [51] . Functional decline and lower physical capacity were evident in both hospitalized (ward and ICU) and non-hospitalized patients at follow-up periods of 1 and 3 months post-COVID-19. Accordingly, physical inactivity as a consequence of quarantine, social distancing and isolation may also be a source of reduced physical capacity and function in persons who are recovering from COVID-19.

Most studies included in the present review reported psychological and neuropsychological issues (anxiety and depression, PTSD, sleep and cognition problems) post-COVID-19, even in individuals with no previously diagnosed mental health problems. This is consistent with a metaanalysis of survivors of previous coronavirus epidemics, which found that one third of patients experienced at least one psychological impairment (PTSD, depression, and anxiety) more than 6 months post-discharge [53] . The prevalence of mental health symptoms varies widely among studies, which may be due to differences in the instruments used to measure these outcomes, and to differences among countries in the impact of cultural or spiritual beliefs suggested that sleep problems may impair both emotional and attentional regulation, and cause irritability and concentration problems [57] . Other studies suggested that sleep problems were a central complication perceived among COVID-19 survivors [29, 37] .

Mental health symptoms were more frequent among females [4, 21, 29, 35] . This may be due to the greater susceptibility of women to stressors, or more likely the higher rate of reporting psychological symptoms [58, 59] . Depression, PTSD, and cognitive problems (concentration and short-term memory impairment) were more frequent among ICU survivors than ward patients [21, 60] . In addition, post-COVID-19 symptoms of cough, fatigue, and chest distress were risk factors for PTSD [60] . The symptoms of PTSD are a well-recognized component of post-ICU syndrome caused by a variety of factors including fear of dying, invasive treatment, pain, delirium, inability to communicate, weakness, immobility, sensory problems, and sleep deprivation [61] . Stress-related symptoms (anxiety, depression, and PTSD) and delirium were associated with an approximately 4-fold increase in the odds of developing neurocognitive impairment [33] , and neurocognitive impairments were related with a 4.5-fold increase in the odds of psychiatric morbidity (anxiety, depression, and PTSD) [33] . Considered together, neuropsychological factors may increase neurocognitive impairments [33, 38] and even mortality [62] , so it is important to consider psychiatric rehabilitation for post-COVID-19 survivors, and measures to strengthen protective factors such as social support that act as stress-buffering mechanisms.

The post-COVID-19 symptoms studied thus far appear to resemble chronic fatigue syndrome, which has been reported after other viral infection [63] . The diagnosis of this syndrome requires the concurrent presence of at least four symptoms among muscle pain, joint pain, post-exertional fatigue, cognitive problems (memory and concentration), and sleep problems, for more than 6 months [64] . Although the symptoms related to this syndrome are present post-COVID-19, the studies included in the present review were all related to follow-up periods shorter than 6 months. 

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection

Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study

Assessment and characterisation of post-COVID-19 manifestations

Clinical sequelae of COVID-19

China: a single-centre longitudinal study

Clinical characteristics and post-intensive care outcomes of COVID-19 pneumonia. Researchsquare

Predictors of health-related quality of life and influencing factors for COVID-19 patients, a follow-up at one month. Front Psychiatry

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy

Post-COVID-19 Functional Status: Relation to age, smoking, hospitalization and comorbidities

Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors. medRxiv

Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study

Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China

Correlation between immune response and self-reported depression during convalescence from COVID-19

Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study

Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

Predictors of postinfectious chronic fatigue syndrome in adolescents

Epidemiology of chronic fatigue syndrome

Quality of Life: Definition and Measurement

Six minute walk distance in healthy subjects aged 55-75 years

Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity

SARS: prognosis, outcome and sequelae

The impact of severe acute respiratory syndrome on the physical profile and quality of life

Intensive care unit acquired muscle weakness in COVID-19 patients

Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia

ICU-acquired weakness

ICU-acquired weakness

Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission

Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan

Identifying clinical and acute psychological risk factors for PTSD after critical care: a systematic review

Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

Chronic fatigue syndrome: the need for subtypes

Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: A meta-analysis

Moodle: The cost effective solution for internet cognitive behavioral therapy (I-CBT) interventions. Technol Health Care

A proposal for multidisciplinary tele-rehabilitation in the assessment and rehabilitation of COVID-19 survivors

Mental health strategies to combat the psychological impact of COVID-19 beyond paranoia and panic

Telerehabilitation in the age of COVID-19: an opportunity for learning health system research

Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials

The effectiveness of various computer-based interventions for patients with chronic pain or functional somatic syndromes: A systematic review and meta-analysis

Predictive factors for a new positive nasopharyngeal swab among patients recovered from covid-19

Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients

Post-infection depression, anxiety and PTSD: a retrospective cohort study with mild COVID-19 patients

Postdischarge health status and symptoms in patients with severe COVID-19

Incidence of post-traumatic stress disorder after coronavirus disease

Anxiety persists after recovery from acquired COVID-19 in anaesthesiologists

Medical Outcomes Study Sleep Scale, WHIIRS: Women's Health Initiative Insomnia Rating Scale, MMSE: Mini Mental State Examination, STAI-Y: State-Trait Anxiety Inventory form Y, ZSDS: Zung Self-Rating Depression Scale, BDI-13: 13-item Beck's Depression Inventory, PTSD: posttraumatic stress disorder, PCL-5: PTSD Checklist-5, HADS: Hospital Anxiety and Depression Scale, GAD-7: Generalized Anxiety Disorder Screener, OCI: Obsessive-Compulsive Inventory, PHQ-9: Patient Health Questionnaire-9

We thank K. Shashok (AuthorAID in the Eastern Mediterranean) for improving the use of English in the manuscript.

J o u r n a l P r e -p r o o f

Chang et al. [76] Crosssectional study